Log in
Enquire now
‌

US Patent 10105346 Isoflavonoid compounds and methods for the treatment of cancer

Patent 10105346 was granted and assigned to MEI Pharma on October, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
MEI Pharma
MEI Pharma
Current Assignee
MEI Pharma
MEI Pharma
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10105346
Date of Patent
October 23, 2018
Patent Application Number
15456182
Date Filed
March 10, 2017
Patent Citations Received
‌
US Patent 11583514 Isoflavonoid compounds and methods for the treatment of cancer
‌
US Patent 10973799 Isoflavonoid compositions and methods for the treatment of cancer
‌
US Patent 10980774 Combination therapies
Patent Primary Examiner
‌
Irina Neagu
Patent abstract

Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10105346 Isoflavonoid compounds and methods for the treatment of cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.